Futuretech Ii Acquisition Quick Ratio (FTII) starting from the second quarter 2025 to second quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Futuretech Ii Acquisition Corp   (NASDAQ: FTII)

Futuretech Ii Acquisition 's Quick Ratio

FTII's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2025, Quick Ratio deteriorated to 0.02 below Futuretech Ii Acquisition 's average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 168 other companies have achieved higher Quick Ratio than Futuretech Ii Acquisition in second quarter 2025. While Quick Ratio total ranking in the second quarter 2025 has deteriorated compared to the prior quarter from 3858 to 5010.

Explain Quick Ratio?
How much Cash & cash equivalents FTII´s has?
What are FTII´s Current Liabilities?




FTII Quick Ratio (Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
Y / Y Current Liabilities Change 16.94 % 54.41 % 384.31 % 35 % 52.64 %
Y / Y Cash & cash equivalent Change 33665.34 % 31517.43 % 222.95 % -65.74 % -99.02 %
Quick Ratio MRQ 0.02 0.02 0 0 0
FTII's Total Ranking # 5010 # 3858 # 3820 # 4659 # 4412
Seq. Current Liabilities Change -5.53 % -69.99 % 294.17 % 4.63 % 24.75 %
Seq. Cash & cash equivalent Change 23.08 % 130.02 % 2914.76 % 295.59 % 15.25 %



Quick Ratio second quarter 2025 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 169
Healthcare Sector # 1033
Overall Market # 5010


Quick Ratio Statistics
High Average Low
1.29 0.24 0
(Mar 31 2022)   (Mar 31 2024)




Financial Statements
Futuretech Ii Acquisition 's Current Liabilities $ 7 Millions Visit FTII's Balance sheet
Futuretech Ii Acquisition 's Cash & cash equivalent $ 0 Millions Visit FTII's Balance sheet
Source of FTII's Sales Visit FTII's Sales by Geography


Cumulative Futuretech Ii Acquisition 's Quick Ratio

FTII's Quick Ratio for the trailling 12 Months

FTII Quick Ratio

(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 121.04 % 140.27 % 160.42 % 88.88 % 173.25 %
Y / Y Cash & cash equivalent TTM Growth 1360.39 % 162.52 % -73.19 % -95.65 % -96.97 %
Quick Ratio TTM 0.01 0 0 0 0
Total Ranking TTM # 3770 # 3339 # 3645 # 3635 # 3637
Seq. Current Liabilities TTM Growth 2.29 % 6.26 % 88.46 % 7.91 % 11.19 %
Seq. Cash & cash equivalent TTM Growth 84.47 % 218.62 % 192.58 % -15.08 % -66.84 %


On the trailing twelve months basis FTII Cash & cash equivalent more than doubled by 33665.34 % in Q2 2025 year on year, faster than Current Liabilities, this led to